α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI),258873-03-9-Amadis Chemical-Amadis Chemical

Accueil > Catalogue de produits > sciences de la vie > nucléoside > α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

[CAS No.258873-03-9] A1255331 α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI) 97%

Rechercher après modification

Numéro de catalogue: A1255331

Cas No.: 258873-03-9

Formule moléculaire: C₂₉H₄₅N₅O₁₂Si

Masse moléculaire: 683.78

MDL No:

EINECS:

Commande/demande de devis/Support technique

Téléphone: 0086-571-89925085
passer commande & demande de renseignements: sales@amadischem.com
support technique: tech@amadischem.com

Demande groupée

*Tous les produits chimiques de notre société sont réservés à un usage en laboratoire et à des fins de fabrication.

contrôle qualité [258873-03-9]

NMR

CNMR

HPLC

LC-MS

documents connexes [258873-03-9]

SDS

Specification

MOL

SDF

Informations de base [258873-03-9]

Synonymes: α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Aspect:

Point de fusion:

Point d’ébullition:

Point d'éclair:

Conditions de stockage: Store in 2-8°C for long term (months)

Pubchem ID:

Smiles: O([Si](C(C)(C)C)(C)C)[C@H]1[C@@H](O[C@]([C@@H](O[C@H]2OC(C(N[C@@H]3C(=O)NCCCC3)=O)=C[C@H](O)[C@@H]2O)C(N)=O)([C@H]1OC)[H])N4C(=O)NC(=O)C=C4

Inchi: InChI=1S/C29H45N5O12Si/c1-29(2,3)47(5,6)46-22-19(42-4)20(44-26(22)34-12-10-17(36)33-28(34)41)21(23(30)38)45-27-18(37)15(35)13-16(43-27)25(40)32-14-9-7-8-11-31-24(14)39/h10,12-15,18-22,26-27,35,37H,7-9,11H2,1-6H3,(H2,30,38)(H,31,39)(H,32,40)(H,33,36,41)/t14-,15-,18-,19+,20-,21+,22+,26+,27+/m0/s1

InchiKey: CDQNAGBKAWYGET-GUTJAGLPSA-N

Informations de sécurité [258873-03-9]

Pictogramme:

Mot de signalement: Warning

UN No.:

Catégorie de danger:

Classe d'emballage:

Mentions de danger: H302;H315;H319;H332;H335

Conseils de prudence: P261;P280;P305+P351+P338

Littérature associée [258873-03-9]

Désolé, aucune littérature correspondante

Produits similaires [258873-03-9]

A1255466 260244-48-2

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2-O-(phenoxythioxomethyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

A1255467 260244-47-1

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

A1255469 258873-02-8

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255470 258873-00-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-2-O-[(4-methylphenoxy)thioxomethyl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

A1255442 258872-96-7

Reason:nucléoside

A1255441 258872-97-8

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-2-O-(phenoxythioxomethyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

A1255381 360772-28-7

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-2,3-bis-O-(1-oxoheptyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

A1255382 360772-27-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-methyl- (9CI)

Reason:nucléoside

Détails du produit [258873-03-9]

Désolé, aucun détail sur le produit

Historique de navigation